IGI Logo

Below are Quote on Ipca labs reported a weak set of numbers for Q4FY21 by Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd   

Ipca Laboratories limited reported total revenue from operations at ₹1134 crores up by 4% YoY from ₹1088 crores in Q4FY20.

Branded export business has done well for the company up by 32% at ₹101 Crores while domestic business up by 1% only at ₹433 Crores and API business reported degrowth of 6% at 260 crores in Q4FY21. EBITDA for the quarter up by 1% at 236 crores as compared to 233 crores in Q4FY20. Profit after tax for the quarter at ₹161 crores in Q4FY21 as compared to ₹83 crores up by 94%. In last year Q4FY20 was hit by the covid 19 pandemic as well as company reported one time exceptional loss in Q4FY20.

Ipca laboratories limited reported a very weak set of numbers, domestic business has not performed as expected while on the export front the company has done better than domestic business. EBITDA margins seems to be under pressure, the company reported EBITDA margins of 20.7% down by 71 bps.

Above views are of the author and not of the website kindly read disclaimer